rs3809997
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001308210.2(TSHZ1):c.1524T>C(p.Pro508Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.392 in 1,613,950 control chromosomes in the GnomAD database, including 125,877 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 11732 hom., cov: 33)
Exomes 𝑓: 0.39 ( 114145 hom. )
Consequence
TSHZ1
NM_001308210.2 synonymous
NM_001308210.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.29
Publications
17 publications found
Genes affected
TSHZ1 (HGNC:10669): (teashirt zinc finger homeobox 1) This gene encodes a colon cancer antigen that was defined by serological analysis of recombinant cDNA expression libraries. The encoded protein is a member of the teashirt C2H2-type zinc-finger protein family and may be involved in transcriptional regulation of developmental processes. Mutations in this gene may be associated with congenital aural atresia syndrome. [provided by RefSeq, Jan 2012]
TSHZ1 Gene-Disease associations (from GenCC):
- aural atresia, congenitalInheritance: AD Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
- congenital vertical talusInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 18-75286931-T-C is Benign according to our data. Variant chr18-75286931-T-C is described in ClinVar as Benign. ClinVar VariationId is 327819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.29 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.406 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSHZ1 | ENST00000580243.3 | c.1524T>C | p.Pro508Pro | synonymous_variant | Exon 2 of 2 | 2 | NM_001308210.2 | ENSP00000464391.1 | ||
| TSHZ1 | ENST00000322038.5 | c.1389T>C | p.Pro463Pro | synonymous_variant | Exon 2 of 2 | 1 | ENSP00000323584.5 | |||
| TSHZ1 | ENST00000584217.1 | n.4068T>C | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.389 AC: 59146AN: 151978Hom.: 11725 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
59146
AN:
151978
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.369 AC: 92604AN: 250962 AF XY: 0.374 show subpopulations
GnomAD2 exomes
AF:
AC:
92604
AN:
250962
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.393 AC: 573864AN: 1461856Hom.: 114145 Cov.: 79 AF XY: 0.393 AC XY: 285692AN XY: 727222 show subpopulations
GnomAD4 exome
AF:
AC:
573864
AN:
1461856
Hom.:
Cov.:
79
AF XY:
AC XY:
285692
AN XY:
727222
show subpopulations
African (AFR)
AF:
AC:
12995
AN:
33478
American (AMR)
AF:
AC:
13835
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
10658
AN:
26136
East Asian (EAS)
AF:
AC:
7214
AN:
39700
South Asian (SAS)
AF:
AC:
33500
AN:
86258
European-Finnish (FIN)
AF:
AC:
20591
AN:
53390
Middle Eastern (MID)
AF:
AC:
2390
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
449220
AN:
1112006
Other (OTH)
AF:
AC:
23461
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
24021
48042
72064
96085
120106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13714
27428
41142
54856
68570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.389 AC: 59176AN: 152094Hom.: 11732 Cov.: 33 AF XY: 0.386 AC XY: 28732AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
59176
AN:
152094
Hom.:
Cov.:
33
AF XY:
AC XY:
28732
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
16122
AN:
41496
American (AMR)
AF:
AC:
5903
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1443
AN:
3470
East Asian (EAS)
AF:
AC:
870
AN:
5164
South Asian (SAS)
AF:
AC:
1823
AN:
4812
European-Finnish (FIN)
AF:
AC:
3880
AN:
10572
Middle Eastern (MID)
AF:
AC:
113
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27882
AN:
67982
Other (OTH)
AF:
AC:
850
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1866
3732
5598
7464
9330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1140
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 17, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aural atresia, congenital Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.